JULIANA ROLLO: Open Payments
NPI 1083338875 · MADISON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,605 in 79 payments from 12 companies in 2025. Trend: 2023 $281 · 2024 $820 · 2025 $1,605
Food & beverage: $1,605
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $369 |
| Otsuka America Pharmaceutical, Inc. | 8 | $208 |
| ABBVIE INC. | 10 | $181 |
| Teva Pharmaceuticals USA, Inc. | 9 | $172 |
| Alkermes, Inc. | 10 | $154 |
| Lundbeck LLC | 8 | $142 |
| E.R. Squibb & Sons, L.L.C. | 5 | $113 |
| Janssen Pharmaceuticals, Inc | 4 | $92 |
| Vanda Pharmaceuticals Inc. | 4 | $76 |
| Axsome Therapeutics, Inc. | 2 | $42 |
Products named: CAPLYTA, REXULTI, VRAYLAR, COBENFY, AUSTEDO XR, ARISTADA, FANAPT, UZEDY.
Industry payments across WV — which companies pay providers there.
